SignatureFD’s Day One Biopharmaceuticals DAWN Stock Holding History

SignatureFD’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33	Closed	-$708	–	3541
2026 Q1	$708	Hold	33	–	–	﹤0.01%	3266
2025 Q4	$308	Hold	33	–	–	﹤0.01%	3272
2025 Q3	$233	Sell	33 -142	-81%	-$977	﹤0.01%	3264
2025 Q2	$1.14K	Sell	175 -71	-29%	-$488	﹤0.01%	2995
2025 Q1	$1.95K	Buy	+246	New	+$2.65K	﹤0.01%	2884

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SignatureFD's DAWN Position: Q2 2026 in Review

SignatureFD sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 33 shares — an estimated $708 sold.

SignatureFD first reported a position in DAWN in Q1 2025 and held it in 5 quarters. The position peaked at $1.95K in Q1 2025. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

SignatureFD reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
SignatureFD sold 33 Day One Biopharmaceuticals shares in Q2 2026, an estimated $708.
SignatureFD first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 5 quarters.
SignatureFD's Day One Biopharmaceuticals position peaked at $1.95K in Q1 2025.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.